Minnesota FOIA #N009559101

Enhancing Treg Therapeutic Efficacy in GVHD

The Twin Cities government agency awarded a contract to the University of Oxford for research on Treg Therapeutic Efficacy in GVHD, with a total obligated amount of $256,506. The award was made on January 18, 2023. The vendor, University of Oxford, is located at The Wellcome Centre for Human Genetics, Roosevelt Drive, Oxford, GBR, with supplier code 11907. The purchase involved a single lot of research services or products related to the specified therapeutic efficacy project. No specific contract requirements or additional OEMs/vendors are mentioned. The award is a single-transaction procurement for research purposes, with no indication of a multi-year or blanket arrangement.

Description

Enhancing Treg Therapeutic Efficacy in GVHD